ARCHIVES

Adherez Issued U.S. Patent for Catenin Molecule Inhibition.

This article is from The Cancer Letter archive.

Vol. 29 No. 27 | July 4, 2003

Download PDF Visit The Full Archive

Related Articles

Brinker Again To Lead Komen As CEO

December 11, 2009

Organ Systems Meeting Canceled

November 19, 1982

OMB Specifies One Year Only Funding for 200 grants Under Supplemental Appropriations Level of 6,200

September 6, 1985

NCI Advisors Ok Study of Cancer In Farmers; Commit $6.6 Million to Five Year Contracts

April 3, 1992

More Debate Due On Organ Site Program; First Round Reviewed By DRG “Slaughtered”

January 28, 1983

Promising Areas Of Research Listed By NCAB Subcommittee

February 12, 1982